InvestorsHub Logo

couldbebetter

12/14/21 2:15 PM

#363171 RE: sstyles #363168

With these low valuations, BP can pick them off, one by one, and end
up paying well below all time highs on most Biotechs out there. As a
bonus for BP, many of these are cash-rich. So BP can buy whatever they
want as the entire group is "on sale" right now.